Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-19T12:11:37.506Z Has data issue: false hasContentIssue false

LO60: Diagnostic utility of creatine kinase in the diagnosis and management of non-ST elevation myocardial infarction

Published online by Cambridge University Press:  11 May 2018

B. Lam*
Affiliation:
University of Ottawa, Ottawa, ON
H. Chaudry
Affiliation:
University of Ottawa, Ottawa, ON
S. Kim
Affiliation:
University of Ottawa, Ottawa, ON
M. Nemnom
Affiliation:
University of Ottawa, Ottawa, ON
I. G. Stiell
Affiliation:
University of Ottawa, Ottawa, ON
G. Hebert
Affiliation:
University of Ottawa, Ottawa, ON
M. Taljaard
Affiliation:
University of Ottawa, Ottawa, ON
R. Beanlands
Affiliation:
University of Ottawa, Ottawa, ON
G. A. Wells
Affiliation:
University of Ottawa, Ottawa, ON
R. Booth
Affiliation:
University of Ottawa, Ottawa, ON
M. Mukarram
Affiliation:
University of Ottawa, Ottawa, ON
V. Thiruganasambandamoorthy
Affiliation:
University of Ottawa, Ottawa, ON
*
*Corresponding author

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Introduction: Creatine kinase (CK) measurement, despite not being recommended for the diagnosis of a Non-ST Elevation Myocardial Infarction (NSTEMI) is still routinely performed in the emergency department (ED) for the workup of NSTEMI. The diagnostic utility of CK among ED patients with suspected NSTEMI is still not well understood. The objectives of this study were to assess: the additional value of CK in NSTEMI diagnosis and the correlation between the highest CK/TNI values and ejection fraction (EF) on follow-up echocardiography among patients with suspected NSTEMI. Methods: This was a prospective cohort study conducted at the Civic and General Campuses of The Ottawa Hospital from March 2014 to March 2016. We enrolled adults (18 years) for whom troponin (TNI) and CK were ordered for chest pain or non-chest pain symptoms within the past 24 hours concerning for NSTEMI and excluded those with suspected ST-Elevation Myocardial Infarction (STEMI). Primary outcome was a 30-day NSTEMI adjudicated by two blinded physicians. Demographics, medical history, and ED CK/TNI values were collected. We used descriptive statistics and report test diagnostic characteristics. Results: Of the 1,663 patients enrolled, 84 patients (5.1%) suffered NSTEMI. The sensitivity and specificity of CK was 30.9% (95%CI 21.1, 40.8) and 91.4% (95%CI 90.0, 92.8) respectively. The sensitivity and specificity of troponin was 96.4% (95%CI 92.4, 100) and 88.1% (95%CI 86.5, 89.7) respectively. Among 3 (0.2%) patients with missed NSTEMI diagnosis with TNI, CK measurements did not add value. The mean CK values were not significantly different between those with normal and abnormal EF on follow-up (132.4 U/L and 146.3 U/L respectively; p=0.44), whereas the mean TNI values were significantly different (0.5 µg/L and 1.3 µg/L respectively; p=0.046). Conclusion: CK measurements neither provide any additional value in the work-up of NSTEMI in the ED nor correlate with EF on follow-up. Discontinuing routine CK measurements would reduce overall costs and improve resource utilization in the ED, and streamline the management of patients in the ED with chest pain.

Type
Oral Presentations
Copyright
Copyright © Canadian Association of Emergency Physicians 2018